Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-9-29
pubmed:abstractText
Hematopoietic progenitor cells (HPCs) can improve cardiac function after myocardial infarction. However, occurrence of arrhythmias is a potential limitation of cell therapy. In this study, we investigated the cardiac electrophysiological properties of ex vivo expanded HPCs, generated by beta-catenin gene transfer, after transcoronary delivery in a murine model of ischemia/reperfusion (I/R) injury.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1421-9751
pubmed:author
pubmed:copyrightInfo
Copyright 2009 S. Karger AG, Basel.
pubmed:issnType
Electronic
pubmed:volume
114
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
199-207
pubmed:meshHeading
pubmed-meshheading:19602881-Animals, pubmed-meshheading:19602881-Arrhythmias, Cardiac, pubmed-meshheading:19602881-Cell Line, pubmed-meshheading:19602881-Electrocardiography, Ambulatory, pubmed-meshheading:19602881-Electrophysiologic Techniques, Cardiac, pubmed-meshheading:19602881-Gene Therapy, pubmed-meshheading:19602881-Gene Transfer Techniques, pubmed-meshheading:19602881-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:19602881-Humans, pubmed-meshheading:19602881-Male, pubmed-meshheading:19602881-Mice, pubmed-meshheading:19602881-Mice, Inbred C57BL, pubmed-meshheading:19602881-Myocardial Infarction, pubmed-meshheading:19602881-Myocardial Reperfusion Injury, pubmed-meshheading:19602881-Myocardium, pubmed-meshheading:19602881-Telemetry, pubmed-meshheading:19602881-beta Catenin
pubmed:year
2009
pubmed:articleTitle
Arrhythmia susceptibility in mice after therapy with beta-catenin-transduced hematopoietic progenitor cells after myocardial ischemia/reperfusion.
pubmed:affiliation
Department of Cardiovascular Medicine, Hannover Medical School, Hannover, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't